RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보 SCOPUS

      오라퀵 테스트를 이용한 HIV감염의 신속 진단 = Rapid Diagnosis of Human Immunodeficiency Virus Infection Using OraQuickⓡ Advance Rapid HIV-1/2 Antibody Test

      한글로보기

      https://www.riss.kr/link?id=A103895295

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background : From medical care perspective regarding HIV, early detection of HIV is critical in effectively managing its sequelae. People who are aware of the fact that they are infected with HIV significantly reduce high risk behaviors, thus limiting transmission to others compared to individuals who are unaware of their HIV serostatus.
      Materials and Methods : HIV rapid test validation study was conducted at Asan medical center using OraQuick Advance Rapid HIV-1/2 Antibody Test which uses oral fluid specimens for the diagnosis of HIV infection. A total of 57 subjects were tested; 53 individuals were confirmed to have HIV infection by the Western blot analysis and 4 individuals were negative for HIV.
      Results : The oral fluid specimens from 52 of 53 infected individuals showed positive reaction to the OraQuick Advance Rapid HIV-1/2 Antibody Test. The test results were negative for the 4 subjects who were negative for HIV. OraQuick Advance Rapid HIV-1/2 Antibody Test's sensitivity was 98.1%, specificity was 100%, positive predictive value was 100%, and negative predictive value was 80%.
      Conclusion : The recently approved OraQuick Advance Rapid HIV-1/2 Antibody Test has the ability to detect HIV antibodies comparable to that of confirmatory tests such as Western blot analysis.
      번역하기

      Background : From medical care perspective regarding HIV, early detection of HIV is critical in effectively managing its sequelae. People who are aware of the fact that they are infected with HIV significantly reduce high risk behaviors, thus limiting...

      Background : From medical care perspective regarding HIV, early detection of HIV is critical in effectively managing its sequelae. People who are aware of the fact that they are infected with HIV significantly reduce high risk behaviors, thus limiting transmission to others compared to individuals who are unaware of their HIV serostatus.
      Materials and Methods : HIV rapid test validation study was conducted at Asan medical center using OraQuick Advance Rapid HIV-1/2 Antibody Test which uses oral fluid specimens for the diagnosis of HIV infection. A total of 57 subjects were tested; 53 individuals were confirmed to have HIV infection by the Western blot analysis and 4 individuals were negative for HIV.
      Results : The oral fluid specimens from 52 of 53 infected individuals showed positive reaction to the OraQuick Advance Rapid HIV-1/2 Antibody Test. The test results were negative for the 4 subjects who were negative for HIV. OraQuick Advance Rapid HIV-1/2 Antibody Test's sensitivity was 98.1%, specificity was 100%, positive predictive value was 100%, and negative predictive value was 80%.
      Conclusion : The recently approved OraQuick Advance Rapid HIV-1/2 Antibody Test has the ability to detect HIV antibodies comparable to that of confirmatory tests such as Western blot analysis.

      더보기

      다국어 초록 (Multilingual Abstract)

      Background : From medical care perspective regarding HIV, early detection of HIV is critical in effectively managing its sequelae. People who are aware of the fact that they are infected with HIV significantly reduce high risk behaviors, thus limiting transmission to others compared to individuals who are unaware of their HIV serostatus.
      Materials and Methods : HIV rapid test validation study was conducted at Asan medical center using OraQuick Advance Rapid HIV-1/2 Antibody Test which uses oral fluid specimens for the diagnosis of HIV infection. A total of 57 subjects were tested; 53 individuals were confirmed to have HIV infection by the Western blot analysis and 4 individuals were negative for HIV.
      Results : The oral fluid specimens from 52 of 53 infected individuals showed positive reaction to the OraQuick Advance Rapid HIV-1/2 Antibody Test. The test results were negative for the 4 subjects who were negative for HIV. OraQuick Advance Rapid HIV-1/2 Antibody Test's sensitivity was 98.1%, specificity was 100%, positive predictive value was 100%, and negative predictive value was 80%.
      Conclusion : The recently approved OraQuick Advance Rapid HIV-1/2 Antibody Test has the ability to detect HIV antibodies comparable to that of confirmatory tests such as Western blot analysis.
      번역하기

      Background : From medical care perspective regarding HIV, early detection of HIV is critical in effectively managing its sequelae. People who are aware of the fact that they are infected with HIV significantly reduce high risk behaviors, thus limiting...

      Background : From medical care perspective regarding HIV, early detection of HIV is critical in effectively managing its sequelae. People who are aware of the fact that they are infected with HIV significantly reduce high risk behaviors, thus limiting transmission to others compared to individuals who are unaware of their HIV serostatus.
      Materials and Methods : HIV rapid test validation study was conducted at Asan medical center using OraQuick Advance Rapid HIV-1/2 Antibody Test which uses oral fluid specimens for the diagnosis of HIV infection. A total of 57 subjects were tested; 53 individuals were confirmed to have HIV infection by the Western blot analysis and 4 individuals were negative for HIV.
      Results : The oral fluid specimens from 52 of 53 infected individuals showed positive reaction to the OraQuick Advance Rapid HIV-1/2 Antibody Test. The test results were negative for the 4 subjects who were negative for HIV. OraQuick Advance Rapid HIV-1/2 Antibody Test's sensitivity was 98.1%, specificity was 100%, positive predictive value was 100%, and negative predictive value was 80%.
      Conclusion : The recently approved OraQuick Advance Rapid HIV-1/2 Antibody Test has the ability to detect HIV antibodies comparable to that of confirmatory tests such as Western blot analysis.

      더보기

      참고문헌 (Reference)

      1 서동우, "응급환자 중 진단되지 않은 HIV(Human Immunodeficiency Virus)감염환자에 대한 분석" 대한응급의학회 14 (14): 258-263, 2003

      2 임현술, "우리나라 전염성 질환의 변화 양상" 대한예방의학회 38 (38): 117-124, 2005

      3 강희정, "애보트 4세대 HIV 항원/항체 검사 시약의 평가" 대한진단검사의학회 26 (26): 39-44, 2006

      4 김태윤, "사람면역결핍바이러스 감염환자의 응급실 방문 양상 및 감염관리의 필요성" 대한응급의학회 16 (16): 458-466, 2005

      5 Woo JH, "The epidemiological characteristics of Korean people with HIV/AIDS" 61 : 347-349, 2001

      6 Choi SM, "Survey of HIV exposure and postexposure prophylaxis among health care workers in Korea" 7 : 65-74, 2002

      7 Bhore AV, "Sensitivity and specificity of rapid HIV testing of pregnant women in India" 14 : 37-41, 2003

      8 Walensky RP, "Revising ex pectations from rapid HIV tests in the emergency department" 149 : 153-160, 2008

      9 WHO Library Catalog uing-in-Publication Data, "Report on the globalH IV/AIDS epidemic 2008: executive summary"

      10 Branson BM, "Rapid tests for HIV antibody" 2 : 76-83, 2000

      1 서동우, "응급환자 중 진단되지 않은 HIV(Human Immunodeficiency Virus)감염환자에 대한 분석" 대한응급의학회 14 (14): 258-263, 2003

      2 임현술, "우리나라 전염성 질환의 변화 양상" 대한예방의학회 38 (38): 117-124, 2005

      3 강희정, "애보트 4세대 HIV 항원/항체 검사 시약의 평가" 대한진단검사의학회 26 (26): 39-44, 2006

      4 김태윤, "사람면역결핍바이러스 감염환자의 응급실 방문 양상 및 감염관리의 필요성" 대한응급의학회 16 (16): 458-466, 2005

      5 Woo JH, "The epidemiological characteristics of Korean people with HIV/AIDS" 61 : 347-349, 2001

      6 Choi SM, "Survey of HIV exposure and postexposure prophylaxis among health care workers in Korea" 7 : 65-74, 2002

      7 Bhore AV, "Sensitivity and specificity of rapid HIV testing of pregnant women in India" 14 : 37-41, 2003

      8 Walensky RP, "Revising ex pectations from rapid HIV tests in the emergency department" 149 : 153-160, 2008

      9 WHO Library Catalog uing-in-Publication Data, "Report on the globalH IV/AIDS epidemic 2008: executive summary"

      10 Branson BM, "Rapid tests for HIV antibody" 2 : 76-83, 2000

      11 Wesolowski LG, "Post-marketing Surveillance Team. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing" 20 : 1661-1666, 2006

      12 O'Connell RJ, "Performance of the OraQuick rapid antibody test for diagnosis of hum an immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy" 41 : 2153-2155, 2003

      13 Branson B, "Performance of new errapid tests for HIV antibody with whole blood and plasma. abstract 599-T" 2002

      14 Donovan BJ, "HIV infection: point-of-care testing" 38 : 670-676, 2004

      15 Korean Society of Infectious Diseases, "HIV infection & AIDS in Infectious Diseases" Koonja Publishing 1175-1180, 2007

      16 Kim JM, "HIV infection" Koonja Publishing 331-344, 2007

      17 Branson BM, "FDA approves OraQ uick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids" 16 : 39-, 2004

      18 Yeom JS, "Evaluation of new third generation LG Anti-HIV 1/2 plus ELISAK it" 14 : 153-159, 2003

      19 Reynolds SJ, "Evaluation of a rapid test for the detection of antibodies to hum an immunodeficiency virus type 1 and 2 in the setting of multiple transmitted viral subtypes" 13 : 171-173, 2002

      20 Choe KW, "Epidemiology of HIV/AIDS : current status, trend and prospect" 50 : 296-302, 2007

      21 Kim JM, "Diagnosis and clinical manifestations of HIV /AIDS" 50 : 303-315, 2007

      22 Chung DR, "Current status and epidem iology of AIDS" 40 : 1548-1553, 1997

      23 황상현, "Bio-Rad Elite Microplate 장비를 이용한 HBs 항원, HCV, HIV 항원-항체검사시약 평가" 대한진단검사의학회 26 (26): 436-441, 2006

      24 Center for Disease Control and Prevention, "A dvancing HIV prevention: new strategies for a changing epidem ic-United States, 2003" 52 : 329-332, 2003

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-02-25 학술지명변경 한글명 : 감염과화학요법 -> Infection and Chemotherapy
      외국어명 : Infection and Chemotherapy -> 미등록
      KCI등재후보
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2009-08-25 학술지명변경 외국어명 : 미등록 -> Infection and Chemotherapy KCI등재후보
      2008-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2008-01-01 평가 등재후보 탈락 (등재후보1차)
      2006-01-01 평가 등재후보 1차 FAIL (등재후보2차) KCI등재후보
      2005-05-27 학술지등록 한글명 : 감염과화학요법
      외국어명 : 미등록
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.24 0.24 0.24
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.2 0.2 0.46 0.29
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼